Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don’t) know

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, November 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (54th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 47 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 16,170 followers.

@dimgrr @rubenivangaalen https://t.co/1FNIKxdKRk relatief recent, en niet onomstreden meen ik.

Reply Repost Favourite

RT @JournalofExper1: Featured Review 💡 𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦𝐬 𝐨𝐟 𝐡𝐲𝐩𝐞𝐫𝐩𝐫𝐨𝐠𝐫𝐞𝐬𝐬𝐢𝐯𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐚𝐟𝐭𝐞𝐫 #𝐢𝐦𝐦𝐮𝐧𝐞𝐜𝐡𝐞𝐜𝐤𝐩𝐨𝐢𝐧𝐭𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫 𝐭𝐡𝐞𝐫𝐚𝐩𝐲: 𝐰𝐡𝐚𝐭 𝐰𝐞 (𝐝𝐨𝐧’𝐭) 𝐤𝐧…

Reply Repost Favourite

RT @JournalofExper1: Featured Review 💡 𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦𝐬 𝐨𝐟 𝐡𝐲𝐩𝐞𝐫𝐩𝐫𝐨𝐠𝐫𝐞𝐬𝐬𝐢𝐯𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐚𝐟𝐭𝐞𝐫 #𝐢𝐦𝐦𝐮𝐧𝐞𝐜𝐡𝐞𝐜𝐤𝐩𝐨𝐢𝐧𝐭𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫 𝐭𝐡𝐞𝐫𝐚𝐩𝐲: 𝐰𝐡𝐚𝐭 𝐰𝐞 (𝐝𝐨𝐧’𝐭) 𝐤𝐧…

Reply Repost Favourite

𝐌𝐞𝐜𝐡𝐚𝐧𝐢𝐬𝐦𝐬 𝐨𝐟 𝐡𝐲𝐩𝐞𝐫𝐩𝐫𝐨𝐠𝐫𝐞𝐬𝐬𝐢𝐯𝐞 𝐝𝐢𝐬𝐞𝐚𝐬𝐞 𝐚𝐟𝐭𝐞𝐫 #𝐢𝐦𝐦𝐮𝐧𝐞𝐜𝐡𝐞𝐜𝐤𝐩𝐨𝐢𝐧𝐭𝐢𝐧𝐡𝐢𝐛𝐢𝐭𝐨𝐫 𝐭𝐡𝐞𝐫𝐚𝐩𝐲: 𝐰𝐡𝐚𝐭 𝐰𝐞 (𝐝𝐨𝐧’𝐭) 𝐤𝐧𝐨𝐰 Enjoy 🖥️ https://t.co/OEomSrYsPH

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.